What Is GHK-Cu? Copper Peptide Research Primer
TL;DR: GHK-Cu is a copper complex formed when the tripeptide glycyl-L-histidyl-L-lysine, or GHK, coordinates a copper ion. GHK contains three amino acids: glycine, histidine, and lysine. GHK-Cu has been studied in areas including copper coordination, fibroblast biology, extracellular-matrix remodeling, collagen-associated processes, cellular signaling, and skin-related research, with evidence ranging from biochemical and cell studies to animal and limited, mixed human research. “Studied for” should not be treated as synonymous with “clinically proven.”
Key Takeaways
- GHK stands for glycyl-L-histidyl-L-lysine, a peptide containing glycine, histidine, and lysine.
- GHK-Cu is the copper-bound form of GHK. GHK has high affinity for copper and forms a coordinated GHK-Cu complex.
- GHK-Cu is commonly described as a copper peptide or copper tripeptide, though database records represent it with more than one molecular formula.
- Research areas include copper coordination, fibroblast activity, extracellular-matrix biology, collagen-associated pathways, tissue remodeling, cellular signaling, and skin biology.
- Findings from laboratory or animal models should not automatically be interpreted as established human outcomes, and some human studies show mixed or negative objective results.
- Vendor-specific classification and research-use-only positioning are addressed near the end of this article.
What Is GHK-Cu Peptide?
GHK-Cu is a copper-binding peptide complex formed when the tripeptide glycyl-L-histidyl-L-lysine, abbreviated GHK, coordinates a copper ion. GHK contains three amino acids, glycine, histidine, and lysine, making it a tripeptide rather than a protein.
Researchers study the copper-bound complex, sometimes called the GHK copper peptide or GHK-Cu copper peptide. These research areas include metal coordination, cellular signaling, fibroblast biology, extracellular-matrix remodeling, and skin-related processes.
Terminology:
- GHK = the peptide itself
- Cu = copper
- GHK-Cu = the copper-bound complex
- Copper peptide = the broader category GHK-Cu falls under
- Copper tripeptide-1 = a name commonly associated with GHK-Cu (see nomenclature note below)
| Property | GHK-Cu |
| Full peptide name | Glycyl-L-histidyl-L-lysine |
| Abbreviation | GHK |
| Copper-bound form | GHK-Cu |
| Amino acids | Glycine, histidine, lysine |
| Sequence | Gly-His-Lys |
| Peptide length | 3 amino acids |
| Compound type | Copper-binding tripeptide complex |
| Common alternative term | Copper tripeptide-1 |
| Key research areas | Copper coordination, fibroblasts, extracellular matrix, collagen-related pathways, cellular signaling, skin biology |
Society Peptide’s current product specifications identify GHK as the amino acid sequence and classify the compound within its copper peptide category. See how Society Peptide classifies its own GHK-Cu material near the end of this article.
Need more than the basic definition? Society Peptide’s complete GHK-Cu research guide expands on mechanisms, evidence levels, research findings, and study limitations.
What Does GHK Stand For?
GHK stands for Gly-His-Lys, which breaks down as:
- Gly = glycine
- His = histidine
- Lys = lysine
These three amino acids connect through peptide bonds to form the tripeptide GHK, also called the GHK peptide. The GHK amino acid sequence, Gly-His-Lys, stays the same whether or not copper is bound.
GHK does not automatically mean GHK-Cu. GHK refers to the peptide on its own. GHK-Cu specifies that the peptide is complexed with copper. A study on GHK is not the same as a study on GHK-Cu.
What Is GHK-Cu Made Of?
GHK-Cu composition consists of two components: the GHK tripeptide and copper.
The GHK tripeptide contributes three amino acids:
- Glycine
- Histidine
- Lysine
Copper is usually discussed as Cu(II) in structural and coordination research. It binds to the peptide through coordination interactions rather than a standard peptide bond. Structural research has examined the Cu(II)-GHK complex using spectroscopic methods, describing a coordinated copper complex involving nitrogen atoms within the peptide structure.
Copper coordination creates a chemically distinct experimental form from uncomplexed GHK, which is why researchers should identify which material was used in a study.
For official nomenclature, the FDA substance record for Copper Tripeptide-1 lists the official name Copper Tripeptide-1 and the preferred substance name prezatide copper. It also lists “GHK complex with copper” as a synonym and identifies a 1:1 relationship between prezatide and the cupric cation.
Having a substance record and unique ingredient identifier does not mean a compound is FDA-approved or reviewed as a drug. It establishes identity, not regulatory status.
Database records for GHK-Cu are not uniform. PubChem, for example, maintains more than one representation of the GHK-copper complex, described with different stoichiometries, formulas, and counterions.
A single database entry is one representation of the compound, not proof that every material labeled GHK-Cu shares one universal molecular formula, molecular weight, or protonation state.
GHK vs. GHK-Cu: What Is the Difference?
This distinction matters directly for interpreting research claims.
| Feature | GHK | GHK-Cu |
| Basic identity | Gly-His-Lys tripeptide | Copper complex of GHK |
| Amino acid sequence | Gly-His-Lys | Gly-His-Lys remains the peptide component |
| Copper specified? | No | Yes |
| Compound category | Tripeptide | Copper-peptide complex |
| Research interpretation | Findings relate to the uncomplexed peptide under the tested conditions | Findings relate to the copper-bound complex under the tested conditions |
Research using GHK should not automatically be described as a direct GHK-Cu experiment. Findings from GHK-Cu should not automatically be attributed to unbound GHK either.
A study examining GHK copper-complex formation research looked specifically at how these copper complexes form and behave. That work is a good illustration of why the free peptide and the copper-complexed form are treated as experimentally distinct materials.
Why Does GHK Bind Copper?
GHK binds Cu(II) through coordination interactions involving donor atoms in the peptide, including the histidine imidazole group. Classic spectroscopic research supports formation of a mononuclear 1:1 Cu(II)-GHK complex at neutral pH.
Other copper-complex species and coordination states can occur as pH and solution conditions change. GHK-Cu should not be treated as one fixed structure under every experimental condition.
Investigations into GHK-Cu molecular structure have examined its Cu(II) coordination using methods such as optical and electron-paramagnetic-resonance spectroscopy, including work on the structure of the GHK-Cu copper complex.
More recent structural work on solution and solid-state Cu(II)-GHK structures describes a monomeric complex in solution, coordinated through amino, amide, and histidine-imidazole nitrogen. A separate dimeric structure has been observed in the solid state.
Copper coordination is a chemical observation. By itself, it does not establish copper transport, tissue delivery, safety, therapeutic activity, or a clinical outcome.
Is GHK-Cu Naturally Occurring?
A review of GHK and its copper complex describes GHK as a naturally occurring peptide identified in human serum, noting its strong affinity for copper and its formation of the GHK-Cu complex. Earlier plasma research on GHK’s association with copper and iron reported the peptide associated with both Cu(II) and Fe(II) in vivo.
That endogenous evidence does not mean every circulating GHK molecule exists as one single 1:1 GHK-Cu species. Metal binding and complex speciation depend on the surrounding conditions.
Laboratory research material is manufactured to a defined specification, so it should not be equated simplistically with the variable metal-bound forms reported in endogenous biology.
What Is GHK-Cu Studied For?
GHK-Cu has been investigated across several research areas involving copper coordination, fibroblast activity, extracellular-matrix biology, collagen and glycosaminoglycan synthesis, tissue remodeling, cellular signaling, oxidative and inflammatory pathways, and skin biology. Evidence strength differs substantially between these areas.
| Research Area | What Researchers Examine | Evidence Type |
| Copper coordination | How GHK forms and stabilizes copper complexes | Spectroscopy and solution-complex chemistry; neutral-pH 1:1 complex plus condition-dependent species |
| Fibroblast biology | Cellular responses associated with matrix production and signaling | Cultured human and animal fibroblast experiments |
| Collagen | Collagen synthesis and matrix-related pathways | Collagen synthesis reported in fibroblast culture |
| Glycosaminoglycans | Production of extracellular-matrix components | Sulfated-GAG synthesis examined in human fibroblasts |
| Matrix remodeling | Production and breakdown of extracellular-matrix components | MMP-2 expression and fibroblast matrix studies |
| Gene expression | Changes in transcriptional patterns and signaling pathways | Prominent systems-level work is on GHK, not directly GHK-Cu |
| Skin biology | Fibroblasts, matrix structure, formulation and tissue response | In-vitro human-skin penetration and preformulation studies |
| Human evidence | Topical GHK-Cu-containing regimens tested in defined clinical settings | Limited and study/formulation-specific; findings are not uniformly positive |
Copper-Binding Research
Researchers studying GHK-Cu copper binding examine coordination chemistry, complex stability, and how peptide structure interacts with copper, including the differences between GHK and GHK-Cu. Society Peptide’s copper-peptide article goes deeper into this chemistry.
Fibroblast and Extracellular-Matrix Research
Fibroblasts are cells heavily involved in extracellular-matrix production, so they appear frequently in GHK-Cu research, and this is one of the better-supported areas because direct primary GHK-Cu experiments exist alongside narrative reviews.
Published cell-culture studies report that GHK-Cu increased collagen synthesis in fibroblast cultures and increased sulfated glycosaminoglycan synthesis in normal human fibroblasts. Separate work found increased MMP-2 expression in dermal fibroblast cultures, an effect also reproduced by copper ions alone in that study, and affected fibroblast growth and growth-factor production in normal and irradiated fibroblast models.
Society Peptide’s collagen and skin research article expands on these findings.
Skin Biology Research
Skin-related research on GHK-Cu touches on fibroblasts, the extracellular matrix, collagen-associated pathways, tissue remodeling, and skin formulation and permeation research.
An in vitro human-skin penetration study of a copper tripeptide examined penetration under defined laboratory conditions. A separate review of GHK-Cu skin permeation research highlights limited penetration through the stratum corneum and outstanding formulation questions.
These studies address permeation and formulation questions; they do not by themselves establish a clinical skin benefit.
Human evidence for topical GHK-Cu products is also mixed rather than uniform, as the evidence-hierarchy examples below illustrate. Current clinical and formulation research also frequently studies GHK-Cu in combination with other ingredients, which makes attribution to GHK-Cu alone difficult.
Society Peptide’s copper-peptide article discusses the skin-barrier questions in more detail.
GHK Gene-Expression Research and Its Relevance to GHK-Cu
Much of the frequently cited gene-expression research in this literature has examined GHK rather than directly exposing cells or animals to a defined GHK-Cu complex. An influential gene-expression study in lung fibroblasts identified GHK through Connectivity Map analysis and subsequently tested GHK itself in human lung fibroblasts.
That experiment examined gene-expression patterns and extracellular-matrix remodeling, but it used GHK, not GHK-Cu.
Those datasets can help generate hypotheses about GHK-associated pathways, but they should not be described as direct evidence that GHK-Cu produces the same gene-expression effects. Separate GHK-Cu studies, including newer animal work, have investigated cellular signaling and gene-expression changes in defined experimental models.
What Does “Studied For” Actually Mean?
What a study can support depends on its model and design. Research categories in this literature include biochemical experiments, cell culture, ex-vivo tissue work, animal models, formulation research, human studies, and reviews.
| Evidence Type | What It Can Show | What It Does Not Prove Alone |
| Biochemical study | Molecular interaction or chemical behavior | Human effect |
| Cell study | Cellular response or mechanism | Clinical effectiveness |
| Animal study | Effect in an intact experimental organism | Equivalent human outcome |
| Human study | Result under defined study conditions | Universal effect across formulations/populations |
| Review | Summary of existing evidence | New experimental proof |
Human studies illustrate why “human evidence exists” does not mean “GHK-Cu works uniformly.” A randomized study of topical GHK-Cu after CO2 laser resurfacing found no significant objective difference in erythema, wrinkles, or overall skin quality, although patient satisfaction was higher in the GHK-Cu group.
By contrast, a multicenter, evaluator-blinded, placebo-controlled trial of topical GHK-Cu gel in diabetic neuropathic ulcers reported greater wound closure for certain plantar ulcers under the tested conditions. These results are not contradictory. They concern different formulations, populations, endpoints, and clinical settings, and neither generalizes to other uses of GHK-Cu.
“GHK-Cu has been studied for X” does not mean “GHK-Cu is proven to treat X.” Identifying the evidence type, model, and conditions behind any given claim is what makes that distinction possible.
Is GHK-Cu a Drug?
GHK-Cu is a copper-peptide complex, not a drug class in itself. In FDA’s May 14, 2026 bulk drug substance update, non-injectable GHK-Cu remained under evaluation in Category 1 for possible inclusion on the 503A bulks list used in pharmacy compounding.
FDA has indicated it intends to consult the Pharmacy Compounding Advisory Committee before the end of February 2027. That evaluation status is not FDA approval of a GHK-Cu drug product.
FDA separately identifies potential safety concerns for compounded injectable GHK-Cu, including possible immunogenicity concerns related to aggregation and peptide impurities. FDA states that human safety information for that route remains limited.
Separately, Society Peptide classifies its own GHK-Cu material as a GHK-Cu research peptide intended strictly for laboratory research, analytical testing, and educational purposes. “Research use only” describes the specific material Society Peptide sells, not an intrinsic scientific classification of the molecule itself.
The material is not intended for personal use, diagnosis, treatment, or human or veterinary consumption.
How Does Society Peptide Classify GHK-Cu Research Material?
Society Peptide’s current specifications list GHK-Cu under its Copper Peptides category, with the sequence identified as GHK. The material is supplied as a lyophilized powder and positioned strictly for research use.
Society Peptide’s product page states ≥99% HPLC purity and links to its laboratory-results documentation. Identity, assay/content, and impurity or purity measurements are treated as distinct analytical attributes under FDA guidance on validation of analytical procedures, each with its own validation expectations.
A chromatographic purity result therefore reflects the specific method used, not a complete profile of the vial’s contents.
Researchers evaluating GHK-Cu material can review GHK-Cu research specifications and the corresponding batch documentation.
Frequently Asked Questions About GHK-Cu
GHK-Cu is a copper complex formed when the tripeptide glycyl-L-histidyl-L-lysine, or GHK, coordinates a copper(II) ion through nitrogen donors in its structure. GHK itself contains three amino acids: glycine, histidine, and lysine. Because the copper is bound through coordination rather than a peptide bond, GHK-Cu is considered a distinct chemical form from unbound GHK.
GHK-Cu is made of the GHK tripeptide, glycine, histidine, and lysine joined by peptide bonds, plus a coordinated copper ion, typically described as Cu(II) in structural research. Solution studies using spectroscopic methods have found the copper coordinated through amino, amide, and histidine-imidazole nitrogen, rather than through a standard peptide bond.
GHK stands for Gly-His-Lys, representing the amino acids glycine, histidine, and lysine joined by peptide bonds into a tripeptide. GHK on its own does not specify copper. Only when this peptide coordinates a copper ion does the compound become GHK-Cu, so the two abbreviations refer to chemically distinct forms.
Yes. GHK-Cu is a copper-peptide complex in which the tripeptide GHK coordinates a copper ion. FDA’s substance database lists prezatide copper under the official name Copper Tripeptide-1 and identifies a 1:1 relationship between prezatide and the cupric cation. “Copper peptide” is a broader category than GHK-Cu alone, and database records vary in exact chemical representation.
GHK is the uncomplexed Gly-His-Lys tripeptide, while GHK-Cu is its copper-bound form. Because coordination changes the compound’s chemical behavior, findings from a study using free GHK should not be attributed to GHK-Cu, and vice versa. Researchers should confirm which specific form was actually used before interpreting any research claim.
GHK-Cu has primarily been studied through biochemical, cell-culture, and preclinical research examining copper coordination, fibroblast activity, collagen and glycosaminoglycan synthesis, matrix metalloproteinase expression, and extracellular-matrix remodeling. Some formulation and limited human research also exists, though results are mixed. This evidence base supports specific mechanistic findings rather than any broad, confirmed clinical outcome.
Copper Tripeptide-1 is the official name FDA’s substance database uses for prezatide copper, with “GHK complex with copper” listed as a synonym. In research and ingredient nomenclature, Copper Tripeptide-1 is commonly associated with GHK-Cu. For chemistry-specific claims, researchers should identify the exact salt, charge state, and stoichiometry used in a given study rather than relying on the name alone.
No. GHK consists of only three amino acids joined by peptide bonds, which classifies it as a tripeptide rather than a protein. Proteins are composed of much longer amino acid chains. This classification does not change when GHK is complexed with copper to form GHK-Cu. The underlying peptide backbone remains a tripeptide.
Society Peptide’s complete GHK-Cu research guide expands on mechanisms, evidence levels, and study limitations. The Society Peptide research library indexes the broader compound catalog.
This material is intended for laboratory research, analytical testing, and educational purposes only. GHK-Cu research material is not intended for personal, human, veterinary, diagnostic, or therapeutic use. No therapeutic, diagnostic, or usage claims are made.